| http://www.w3.org/ns/prov#value | - SOUTH SAN FRANCISCO, CA--(Marketwire - June 19, 2012) - Highlighted Links CYTK Website Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that it is concurrently offering to sell, subject to market and other conditions, (i) shares of its common stock and corresponding warrants to purchase 0.60 of a share of common stock for each share purchased, in an underwritten public offering, and (ii)
|
